ArticleCancer2019

Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.

Stefania Maraka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.